{
  "release_id": "a25293eeae6350fb",
  "id": "cardio:pravastatin",
  "owner": "cardio",
  "kind": "drug",
  "slug": "pravastatin",
  "name": "Pravastatin",
  "aliases": [],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "Pravastatin is a statin, a medicine taken by mouth to lower LDL cholesterol. The FDA label says it is indicated to lower LDL cholesterol, as an adjunct to diet, in adults with primary hyperlipidemia.",
  "summary_technical": "RxNorm ingredient 42463; UNII 3M8608UQ61. The label names the substance as pravastatin sodium, so UNII 3M8608UQ61 is the UNII of the salt form and is a broad match. MeSH descriptor D017035 is Pravastatin. Class: HMG-CoA Reductase Inhibitor (FDA established pharmacologic class, RxClass). The label read is the Teva Pharmaceuticals USA, Inc. label for pravastatin sodium tablets (pravastatin sodium), application ANDA076056, effective 2024-01-01 in openFDA. This page records the label indication and the class only: no trial result and no dose is given.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-11-07",
  "last_evidence_check": "2026-11-07",
  "next_review_due": null,
  "identifiers": [
    {
      "scheme": "rxnorm",
      "value": "42463",
      "normalized_value": "42463",
      "match": "exact",
      "version": null,
      "label": null,
      "from_source": false
    },
    {
      "scheme": "unii",
      "value": "3M8608UQ61",
      "normalized_value": "3M8608UQ61",
      "match": "broad",
      "version": null,
      "label": null,
      "from_source": false
    },
    {
      "scheme": "mesh",
      "value": "D017035",
      "normalized_value": "D017035",
      "match": "exact",
      "version": null,
      "label": null,
      "from_source": false
    }
  ],
  "navigation": {
    "cardio": {
      "condition-area": [
        "coronary-and-vascular-disease",
        "risk-and-prevention"
      ]
    }
  },
  "payload": {
    "level": "substance",
    "mechanism": null
  },
  "content_digest": "0e00b08018a41e5fbf4133cc6170059151f023cad6aeba514448e871891ca632",
  "review": {
    "content_digest": "0e00b08018a41e5fbf4133cc6170059151f023cad6aeba514448e871891ca632",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [
    {
      "release_id": "a25293eeae6350fb",
      "id": "cardio:claim-fda-pravastatin-label-indications",
      "owner": "cardio",
      "subject_entity_id": "cardio:pravastatin",
      "category": "descriptive",
      "statement": "The US label of pravastatin sodium tablets (pravastatin sodium), in the Teva Pharmaceuticals USA, Inc. version dated 2024-01-01 in openFDA, lists the medicine to lower LDL cholesterol, as an adjunct to diet, in adults with primary hyperlipidemia.",
      "context": {
        "id": "cardio:ctx-fda-pravastatin-label-us",
        "label": "People for whom the US label of pravastatin lists an indication: adults with primary hyperlipidemia",
        "recipient": "adult",
        "population": "Patients described in the indications section of the label, the passage read here being the adult LDL-cholesterol indication.",
        "care_setting": "Prescription medicine, as described in the US label",
        "geography": "United States (label of the US Food and Drug Administration)",
        "life_stage_note": "Adults, as the passage read states",
        "life_stage_terms": null,
        "gestational_age_min_days": null,
        "gestational_age_max_days": null,
        "gestational_age_basis": null,
        "postnatal_age_min_days": null,
        "postnatal_age_max_days": null,
        "gestational_age_status": null,
        "postnatal_age_status": null,
        "followup_description": "Not applicable (label statement)",
        "eligibility": {
          "inclusion": [
            "Adults with primary hyperlipidemia"
          ],
          "exclusion": []
        }
      },
      "evidence_stage": "not_applicable",
      "certainty": "not_assessed",
      "certainty_method": null,
      "limitations": "This claim records one thing the label says the medicine is indicated for. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The label lists other indications that were not recorded; contraindications, doses, interactions and warnings were not read. Labels change, and openFDA also lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.",
      "editorial_state": "draft",
      "checked_at": "2026-11-07",
      "next_review_due": null,
      "valid_from": null,
      "valid_to": null,
      "citations": [
        {
          "evidence_role": "supports",
          "locator": "results[0].indications_and_usage[0], 1 INDICATIONS AND USAGE",
          "applicability_note": "The label sentence that gives the LDL-cholesterol indication.",
          "snapshot": {
            "id": "cardio:openfda-label-pravastatin-teva-2026-11-07",
            "retrieved_at": "2026-11-08T02:10:19Z",
            "content_hash": "ed95365689d1e69f921584e7adab83c556914d79322fb72940fb9d38affe023f",
            "source_effective_date": "2024-01-01",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-pravastatin-teva",
            "source_type": "regulator",
            "title": "openFDA drug label record for pravastatin sodium tablets (pravastatin sodium), Teva Pharmaceuticals USA, Inc. label: indications and substance identifiers",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%2299e0e848-f8f3-4b42-b880-8fbc42633948%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 99e0e848-f8f3-4b42-b880-8fbc42633948 (manufacturer Teva Pharmaceuticals USA, Inc., application ANDA076056), returned on 2026-11-07. The label text is dated 2024-01-01 (effective_time). Other openFDA records of pravastatin labels from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-07, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/wf-openfda-label-pravastatin-teva.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "context",
          "locator": "results[0].effective_time",
          "applicability_note": "Effective date of the label text read, 20240101.",
          "snapshot": {
            "id": "cardio:openfda-label-pravastatin-teva-2026-11-07",
            "retrieved_at": "2026-11-08T02:10:19Z",
            "content_hash": "ed95365689d1e69f921584e7adab83c556914d79322fb72940fb9d38affe023f",
            "source_effective_date": "2024-01-01",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-pravastatin-teva",
            "source_type": "regulator",
            "title": "openFDA drug label record for pravastatin sodium tablets (pravastatin sodium), Teva Pharmaceuticals USA, Inc. label: indications and substance identifiers",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%2299e0e848-f8f3-4b42-b880-8fbc42633948%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 99e0e848-f8f3-4b42-b880-8fbc42633948 (manufacturer Teva Pharmaceuticals USA, Inc., application ANDA076056), returned on 2026-11-07. The label text is dated 2024-01-01 (effective_time). Other openFDA records of pravastatin labels from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-07, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/wf-openfda-label-pravastatin-teva.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        }
      ],
      "review": {
        "content_digest": "4463deb7eb3c1cc9cee1318eeba3ceebaf9968d22e37ff97fa51b160d4cb4818",
        "current": [],
        "conflicting": [],
        "stale": [],
        "inactive": []
      },
      "api_path": "api/v1/claims/cardio--claim-fda-pravastatin-label-indications.json"
    }
  ],
  "decisions": [],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "subtype_of",
        "label": "Pravastatin is an HMG-CoA reductase inhibitor (FDA established pharmacologic class in RxClass)",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:statins",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-42463-2026-11-07",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[1].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "evaluated_for",
        "label": "FDA label lists lowering LDL cholesterol as an indication",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "cardio:dyslipidemia",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-pravastatin-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "part_of",
        "label": "Files under this front",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:front-medicines",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": [
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct01301066",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct01301066-2014-04-29",
          "locator": "protocolSection.armsInterventionsModule.interventions[1].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct01816997",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct01816997-2013-11-18",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct03510884",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct03510884-2023-05-06",
          "locator": "protocolSection.armsInterventionsModule.interventions[4].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct03944512",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct03944512-2025-12-23",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ]
  },
  "page_path": "drugs/pravastatin/",
  "context_path": "api/v1/context/cardio--pravastatin.md"
}
